Jeffery Lee - Sabra Health Ex Officer
| SBC Stock | EUR 17.49 0.09 0.52% |
Insider
Jeffery Lee is Ex Officer of Sabra Health Care
| Phone | 772 287 4000 |
| Web | https://www.seacoastbanking.com |
Sabra Health Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0241) %, meaning that it generated substantial loss on money invested by shareholders. Sabra Health's management efficiency ratios could be used to measure how well Sabra Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | INSIDER Age | ||
| Joseph Adamo | Genco Shipping Trading | 61 | |
| Ivo Kempenaer | Genco Shipping Trading | N/A | |
| Apostolos Zafolias | Genco Shipping Trading | 44 | |
| John Wobensmith | Genco Shipping Trading | 53 | |
| Peter CFA | Genco Shipping Trading | N/A | |
| Captain Hughes | Genco Shipping Trading | 48 | |
Management Performance
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 |
Sabra Health Care Leadership Team
Elected by the shareholders, the Sabra Health's board of directors comprises two types of representatives: Sabra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sabra. The board's role is to monitor Sabra Health's management team and ensure that shareholders' interests are well served. Sabra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sabra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Nyland, Ex Management | ||
| Talya NevoHacohen, Chief VP | ||
| Michael Costa, CFO VP | ||
| Jeffrey Bray, Ex Ops | ||
| Darrin Smith, Ex Investments | ||
| Lukas CFA, VP Fin | ||
| Michael Sonego, Ex Exec | ||
| Joseph Forlenza, Ex Officer | ||
| Daniel Chappell, Chief VP | ||
| Charles Cross, Ex Pres | ||
| Juliette Kleffel, Ex Officer | ||
| Jeffery Lee, Ex Officer | ||
| Jennifer Reissman, Ex Officer | ||
| Tracey Dexter, Ex CFO | ||
| Eliza Gozar, VP Investments | ||
| Charles Shaffer, Pres Chairman | ||
| Harold Andrews, Consultant | ||
| Richard Matros, Pres Chairman |
Sabra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sabra Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 5.1 B | |||
| Shares Outstanding | 231.16 M | |||
| Shares Owned By Insiders | 1.35 % | |||
| Shares Owned By Institutions | 90.40 % | |||
| Price To Earning | 25.24 X | |||
| Price To Book | 0.90 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sabra Stock
Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.